戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1          Activation of GATA3 was analysed by electrophoretic mobility shift assay.
2 2 and AIL5 promoter regions was confirmed by electrophoretic mobility shift assay.
3 is significantly higher than for dsDNA in an electrophoretic mobility shift assay.
4  stable, sequence-specific RNA binding in an electrophoretic mobility shift assay.
5  by chromatin immunoprecipitation (ChIP) and electrophoretic mobility shift assay.
6  the bhuA promoter region was observed in an electrophoretic mobility shift assay.
7 raction of DNA and protein was determined by electrophoretic mobility shift assay.
8 th purified NAC to produce a shifted band by electrophoretic mobility shift assay.
9 d with nonmethylated G or A alleles in a gel electrophoretic mobility shift assay.
10 oscopy, relative viscosity measurements, and electrophoretic mobility shift assay.
11  assessed for binding of nuclear proteins by electrophoretic mobility shift assay.
12 ofluorescence, subcellular fractionation and electrophoretic mobility shift assay.
13 nation was used; DNA binding was analyzed by electrophoretic mobility shift assay.
14              NFkB activation was measured by electrophoretic mobility shift assay.
15 he optimal N/P ratio was 50 as determined by electrophoretic mobility shift assay.
16 nt using flow cytometry, transactivation and electrophoretic mobility shift assays.
17 recombinant PenR and PntR were identified by electrophoretic mobility shift assays.
18 itative reverse transcriptase (qRT)-PCR, and electrophoretic mobility shift assays.
19 ased affinity for the biotin operator DNA in electrophoretic mobility shift assays.
20 ement (NRE) at this location by ChIP-seq and electrophoretic mobility shift assays.
21 anning and tested using light scattering and electrophoretic mobility shift assays.
22 urified CepR bound to each of these sites in electrophoretic mobility shift assays.
23 la BabR binds to the virB promoter region in electrophoretic mobility shift assays.
24 , hpd, and dhcA promoters in vitro by use of electrophoretic mobility shift assays.
25 somal target integration sequences (attB) in electrophoretic mobility shift assays.
26 inding specificities, which was confirmed by electrophoretic mobility shift assays.
27 pla3 using chromatin immunoprecipitation and electrophoretic mobility shift assays.
28 red for 12 of these promoters by competition electrophoretic mobility shift assays.
29 ormed a more stable complex with Bdnf RNA in electrophoretic mobility shift assays.
30 to the cydAB promoter DNA was analyzed using electrophoretic mobility shift assays.
31 scription factor binding was investigated by electrophoretic mobility shift assays.
32                                              Electrophoretic mobility shift assay analysis indicates
33                                              Electrophoretic mobility shift assay analysis of nuclear
34                                              Electrophoretic mobility shift assay analysis with antib
35 nding sites through DNase I footprinting and electrophoretic mobility shift assay analysis.
36 sitivity to both sulforaphane and diamide in electrophoretic mobility shift assay analysis.
37 ctor such as U2AF65, as determined by an RNA electrophoretic mobility shift assay and a chromatin imm
38 mplex to the PUMA promoter was identified by electrophoretic mobility shift assay and a chromatin imm
39 the snRNA duplex during di-snRNP assembly by electrophoretic mobility shift assay and accompanying co
40 erse ERalpha-bound loci were validated using electrophoretic mobility shift assay and ChIP-polymerase
41                                              Electrophoretic mobility shift assay and chromatin immun
42                              We then used an electrophoretic mobility shift assay and chromatin immun
43    Promoter activation studies combined with electrophoretic mobility shift assay and chromatin immun
44                                              Electrophoretic mobility shift assay and chromatin immun
45                                    Promoter, electrophoretic mobility shift assay and chromatin immun
46 1 to HIF-1alpha promoter was corroborated by electrophoretic mobility shift assay and chromatin immun
47                                              Electrophoretic mobility shift assay and chromatin immun
48                                              Electrophoretic mobility shift assay and chromatin immun
49 appaB transcription factor were validated by electrophoretic mobility shift assay and chromatin immun
50 tative STAT-binding sequence at -476 nt, and electrophoretic mobility shift assay and chromatin immun
51                                           By electrophoretic mobility shift assay and chromatin immun
52 lement in the AOC1 promoter was confirmed by electrophoretic mobility shift assay and chromatin immun
53                                              Electrophoretic mobility shift assay and chromatin immun
54                                              Electrophoretic mobility shift assay and chromatin IP re
55                SNP function was evaluated by electrophoretic mobility shift assay and promoter lucife
56 BI to directly activate ODO1, as revealed by electrophoretic mobility shift assay and yeast one-hybri
57 promoter and quantified it using competitive electrophoretic mobility shift assays and chromatin immu
58 ple sites in the promoter was verified using electrophoretic mobility shift assays and chromatin immu
59     Assays for ubiquitin conjugation include electrophoretic mobility shift assays and detection of e
60                                    Moreover, electrophoretic mobility shift assays and DNase I footpr
61        In support of this competition model, electrophoretic mobility shift assays and DNase I footpr
62 inity binding site for BldD, as was shown by electrophoretic mobility shift assays and DNase I footpr
63                                              Electrophoretic mobility shift assays and DNase I footpr
64                                        Using electrophoretic mobility shift assays and fluorescence a
65 ssed mutant proteins, p.Q65X and p.Q119X, by electrophoretic mobility shift assays and immunoblot ana
66                                              Electrophoretic mobility shift assays and intrinsic Trp
67                               The results of electrophoretic mobility shift assays and quantitative a
68 of these genes by VqsM has been confirmed by electrophoretic mobility shift assays and quantitative r
69  of TALE DNA recognition, using quantitative electrophoretic mobility shift assays and reporter gene
70                                     Based on electrophoretic mobility shift assays and RNA footprinti
71                                              Electrophoretic mobility shift assays and surface plasmo
72  NER pathways on these lesions, we performed electrophoretic mobility-shift assays and chromatin immu
73       We used chromatin immunoprecipitation, electrophoretic mobility shift assay, and both knockdown
74                    Through promoter mapping, electrophoretic mobility shift assay, and chromatin immu
75                               Bioinformatic, electrophoretic mobility shift assay, and gene expressio
76 ction, immunoblotting, immunohistochemistry, electrophoretic mobility shift assay, and luciferase rep
77 AR RNA interaction using UV melting studies, electrophoretic mobility shift assay, and RNase A footpr
78 ion of the dsbD promoter was demonstrated by electrophoretic mobility shift assay, and the MisR bindi
79                      Co-immunoprecipitation, electrophoretic mobility shift assays, and chromatin imm
80 izing cell-based luciferase reporter assays, electrophoretic mobility shift assays, and chromatin imm
81              Bacterial one-hybrid screening, electrophoretic mobility shift assays, and coimmunopreci
82 ing activity both in vitro, as determined by electrophoretic mobility shift assays, and in cells, as
83  experimentally validated, both in vitro, by electrophoretic mobility shift assays, and in vivo, by c
84    The WRKY70 binding site was defined using electrophoretic mobility shift assays, and its importanc
85  Quantitative chromatin immunoprecipitation, electrophoretic mobility shift assays, and luciferase re
86                Using saturation mutagenesis, electrophoretic mobility shift assays, and RNA-sequencin
87 , microscopy, chromatin immunoprecipitation, electrophoretic mobility shift assays, and VE-cadherin-l
88 udy describes a sensitive acetyl transferase electrophoretic mobility shift assay applicable both for
89                                              Electrophoretic mobility shift assay as well as chromati
90                   Moreover, as determined by electrophoretic mobility shift assays, BioR binds the pr
91 mount of metal ion to produce a shift in the electrophoretic mobility shift assay, but unlike the wil
92                                  Using EMSA (electrophoretic mobility shift assay), ChIP (chromatin i
93  technology, gene reporter luciferase assay, electrophoretic mobility shift assay, chromatin immunopr
94                    Co-transfection analyses, electrophoretic mobility shift assays, chromatin immunop
95                            We also performed electrophoretic mobility shift assays, competition exper
96 ent, which chromatin immunoprecipitation and electrophoretic mobility shift assays confirm are bound
97                                              Electrophoretic mobility shift assay confirmed that STAT
98                                 Furthermore, electrophoretic mobility shift assays confirmed specific
99                                              Electrophoretic mobility shift assays confirmed that PTB
100            Chromatin immunoprecipitation and electrophoretic mobility shift assay data revealed that
101                                              Electrophoretic mobility shift assays demonstrate that c
102 tivation experiments, mutation analyses, and electrophoretic mobility shift assays demonstrate that t
103                                              Electrophoretic mobility shift assay demonstrated that F
104          Consistent with these observations, electrophoretic mobility shift assay demonstrated that p
105                 Transactivation analysis and electrophoretic mobility shift assay demonstrated that P
106                                              Electrophoretic mobility shift assays demonstrated decre
107                                              Electrophoretic mobility shift assays demonstrated incre
108                                              Electrophoretic mobility shift assays demonstrated NFATc
109                                              Electrophoretic mobility shift assays demonstrated that
110                                              Electrophoretic mobility shift assays demonstrated that
111                                              Electrophoretic mobility shift assays demonstrated that
112                                              Electrophoretic mobility shift assays demonstrated that
113                                              Electrophoretic mobility shift assays demonstrated that
114                                              Electrophoretic mobility shift assays demonstrated that
115                                              Electrophoretic mobility shift assays demonstrated that
116                   Reporter gene analysis and electrophoretic mobility shift assays demonstrated that
117                                              Electrophoretic mobility shift assays demonstrated that
118                                              Electrophoretic mobility shift assays demonstrated that
119                                              Electrophoretic mobility shift assays demonstrated that
120                                     In vitro electrophoretic mobility shift assays demonstrated the p
121 g approach was independently validated by an electrophoretic mobility shift assay demonstrating hMutS
122                                              Electrophoretic mobility shift assays determined that th
123                                        Using electrophoretic mobility shift assay, DNaseI footprintin
124                                              Electrophoretic mobility shift assay documented the acti
125                                              Electrophoretic mobility shift assay (EMSA) analysis dis
126                                              Electrophoretic mobility shift assay (EMSA) analysis of
127                                              Electrophoretic mobility shift assay (EMSA) analysis sho
128               These values were confirmed by electrophoretic mobility shift assay (EMSA) analysis, wh
129 n vitro using luciferase reporter assays and electrophoretic mobility shift assay (EMSA) analysis.
130                                 Here, we use electrophoretic mobility shift assay (EMSA) and atomic f
131                                              Electrophoretic mobility shift assay (EMSA) and chromati
132                                        Using electrophoretic mobility shift assay (EMSA) and chromati
133  to a 45-bp binding site as determined by an electrophoretic mobility shift assay (EMSA) and DNase I
134                                        Using electrophoretic mobility shift assay (EMSA) and isotherm
135                                              Electrophoretic mobility shift assay (EMSA) experiments
136   In this study, circular dichroism (CD) and electrophoretic mobility shift assay (EMSA) experiments
137 ion (ChIP) assay for our in vivo studies and electrophoretic mobility shift assay (EMSA) for our in v
138               Point mutation analysis and an electrophoretic mobility shift assay (EMSA) suggested th
139                                 We performed electrophoretic mobility shift assay (EMSA) using wild-t
140                                              Electrophoretic mobility shift assay (EMSA) was used to
141 dict transcription factor binding sites, and electrophoretic mobility shift assay (EMSA) was used to
142                                      Second, electrophoretic mobility shift assay (EMSA) was used to
143 oid site cleaving enzyme-1 (BACE1) genes for electrophoretic mobility shift assay (EMSA) with differe
144 mntH promoter region were demonstrated in an electrophoretic mobility shift assay (EMSA), and a Mur b
145                                  Luciferase, electrophoretic mobility shift assay (EMSA), and ChIP an
146 d A-261T, using transfection/cotransfection, electrophoretic mobility shift assay (EMSA), and chromat
147        Chromatin immunoprecipitation (ChIP), electrophoretic mobility shift assay (EMSA), and lucifer
148 2 also regulates the Bdnf gene, we performed electrophoretic mobility shift assay (EMSA), chromatin i
149                                        Using electrophoretic mobility shift assay (EMSA), purified Ls
150    CcrB DNA binding, as assessed in vitro by electrophoretic mobility shift assay (EMSA), revealed th
151  to viral terminal repeat DNA as assessed by electrophoretic mobility shift assay (EMSA), the mutatio
152 f NF-Y to ICB1 and ICB2 was studied using an electrophoretic mobility shift assay (EMSA).
153 n with the znuD promoter was demonstrated by electrophoretic mobility shift assay (EMSA).
154                                              Electrophoretic mobility shift assays (EMSA) and chromat
155                                         Both electrophoretic mobility shift assays (EMSA) and chromat
156     Chromatin immunoprecipitation (ChIP) and electrophoretic mobility shift assays (EMSA) experiments
157                                              Electrophoretic mobility shift assays (EMSA) indicated t
158 OLOGY/PRINCIPAL FINDINGS: Luciferase assays, electrophoretic mobility shift assays (EMSA), and RNA ex
159                    Using recombinant ArsR in electrophoretic mobility shift assays (EMSA), we localiz
160 e fashion and to bind TR DNA, as assessed by electrophoretic mobility shift assays (EMSA).
161 from an oligonucleotide library by employing electrophoretic mobility shift assays (EMSA).
162  pattern and also bound TR DNA as assayed by electrophoretic mobility shift assays (EMSA).
163  analyzed for DNA binding with the use of an electrophoretic mobility-shift assay (EMSA) and confocal
164                                Additionally, electrophoretic mobility shift assays (EMSAs) and DNase
165                                              Electrophoretic mobility shift assays (EMSAs) confirmed
166 ted by susceptibility and efflux assays, and electrophoretic mobility shift assays (EMSAs) confirmed
167                                 Importantly, electrophoretic mobility shift assays (EMSAs) determined
168   We describe a platform for high-throughput electrophoretic mobility shift assays (EMSAs) for identi
169                                              Electrophoretic mobility shift assays (EMSAs) identified
170 es and target antigen, we introduce affinity electrophoretic mobility shift assays (EMSAs) in a high-
171                                              Electrophoretic mobility shift assays (EMSAs) revealed t
172                    Western blot analysis and electrophoretic mobility shift assays (EMSAs) showed tha
173           We performed EA-binding assays and electrophoretic mobility shift assays (EMSAs) to elucida
174                                              Electrophoretic mobility shift assays (EMSAs) were perfo
175                                              Electrophoretic mobility shift assays (EMSAs) were used
176 transcription factor binding was analyzed by electrophoretic mobility shift assays (EMSAs) with Jurka
177 etween nmoA and nmoR, which was confirmed by electrophoretic mobility shift assays (EMSAs) with the p
178 a combination of protein purification steps, electrophoretic mobility shift assays (EMSAs), and mass
179  as hexahistidine fusion proteins, and using electrophoretic mobility shift assays (EMSAs), the IHFal
180 dependent methods, including SW blotting and electrophoretic mobility shift assays (EMSAs).
181                Analytical gel filtration and electrophoretic mobility shift assays establish that ini
182                             A combination of electrophoretic mobility shift assay experiments and bio
183                                              Electrophoretic mobility shift assay experiments demonst
184                                              Electrophoretic mobility shift assay experiments illustr
185 omplex formed with infected cell extracts in electrophoretic mobility shift assay experiments, (iv) s
186                      Luciferase reporter and electrophoretic-mobility shift assay for the FUT6 varian
187                                              Electrophoretic mobility shift assays further demonstrat
188                                              Electrophoretic mobility shift assay gel shift patterns
189 cant increase in ATF3 promoter activity, and electrophoretic mobility shift assay identified this reg
190 , deletion studies, mutagenesis studies, and electrophoretic mobility shift assays identified a PPARa
191                  Transient transfections and electrophoretic mobility shift assays identified CAAT en
192 ants in this window for functional impact on electrophoretic mobility shift assay identifies rs806371
193 e lead SNP rs4888378; multiplexed competitor electrophoretic mobility shift assays implicated FOXA as
194 identified as high-affinity Oct-1 binding by electrophoretic mobility shift assay in vitro and chroma
195                                        Using electrophoretic mobility shift assays in HeLa cell extra
196  complex with a 34mer double-stranded DNA in electrophoretic mobility-shift assays, independent of di
197                                              Electrophoretic mobility shift assay indicated that P-Rh
198                                              Electrophoretic mobility shift assays indicated that Bpa
199                                              Electrophoretic mobility shift assays indicated that spe
200                                 Furthermore, electrophoretic mobility shift assays indicated the pres
201 affinity and pattern of shifted complexes in electrophoretic mobility shift assays is responsive to t
202  shown by ChIP-assays, bind KLF16 in vivo In electrophoretic mobility shift assays, KLF16 binds speci
203  a cytokine secretion assay of IL-17, and by electrophoretic mobility shift assay of activating prote
204 appaB-luciferase reporter into cell lines or electrophoretic mobility shift assay of lysate.
205                                              Electrophoretic mobility shift assays on the shortlist d
206  In combination with mutational analysis and electrophoretic mobility shift assays, our results provi
207 itro binding studies utilizing a pulse-chase electrophoretic mobility shift assay protocol revealed t
208                                              Electrophoretic mobility shift assays provide further ev
209 se to DNAm changes upon modulation of HOTAIR Electrophoretic mobility shift assays provided further e
210                                       In the electrophoretic mobility shift assay, purified recombina
211                                              Electrophoretic mobility shift assays, quantitative reve
212                                        Using electrophoretic mobility shift assay, real-time PCR, and
213 vo and in vitro by coimmunoprecipitation and electrophoretic mobility shift assays, respectively.
214                                              Electrophoretic mobility shift assay results demonstrate
215                                              Electrophoretic mobility shift assays reveal two discret
216 re also up-regulated in resistant plants and electrophoretic mobility shift assay revealed sequence-s
217                                           An electrophoretic mobility shift assay revealed similarity
218                                              Electrophoretic mobility shift assay revealed that curcu
219                                              Electrophoretic mobility shift assay revealed that PMA s
220                                              Electrophoretic mobility shift assays revealed a direct
221                                              Electrophoretic mobility shift assays revealed direct bi
222                                              Electrophoretic mobility shift assays revealed increased
223                                              Electrophoretic mobility shift assays revealed that ChrA
224                                              Electrophoretic mobility shift assays revealed that FKPB
225                                              Electrophoretic mobility shift assays revealed that indi
226                                              Electrophoretic mobility shift assays revealed that NFAT
227                                              Electrophoretic mobility shift assays revealed that RegX
228                                              Electrophoretic mobility shift assays revealed that SarX
229                Yeast one-hybrid analysis and electrophoretic mobility shift assays revealed that the
230                                              Electrophoretic mobility shift assays revealed that Tim
231                                          RNA electrophoretic mobility shift assays (RNA-EMSA) were us
232                                              Electrophoretic mobility shift assays show that Mn(II) r
233                                              Electrophoretic mobility shift assays show that RTV1 bin
234                                              Electrophoretic mobility shift assays show that the K pr
235                                              Electrophoretic mobility shift assay showed RUNX1 bindin
236                                           An electrophoretic mobility shift assay showed that Arn pre
237                                              Electrophoretic mobility shift assay showed that OsbZIP4
238                                              Electrophoretic mobility shift assay showed that PU.1 pr
239                                              Electrophoretic mobility shift assays showed that AaNAC2
240  A bacterial one-hybrid system technique and electrophoretic mobility shift assays showed that AioR i
241                               In this study, electrophoretic mobility shift assays showed that AtWRKY
242                                              Electrophoretic mobility shift assays showed that Fur bi
243       Chromatin-Immunoprecipitation-qPCR and electrophoretic mobility shift assays showed that MdMYB8
244 r of AAO3 in mesophyll cell protoplasts, and electrophoretic mobility shift assays showed that NAP ca
245                                   Additional electrophoretic mobility shift assays showed that P64 bo
246                          Gene expression and electrophoretic mobility shift assays showed that the 5.
247                                              Electrophoretic mobility shift assays showed that the CR
248                                              Electrophoretic mobility shift assay shows that unphosph
249                                           In electrophoretic mobility shift assay studies, intragenic
250           DNA-protein interaction studies by electrophoretic mobility shift assay suggested hypoxia r
251                                              Electrophoretic mobility shift assay suggested that the
252 ers, but some of these interact with ABI4 in electrophoretic mobility shift assays, suggesting that s
253                                 We showed by electrophoretic mobility shift assay that the C terminus
254                         We also show through electrophoretic mobility shift assays that OsARID3 speci
255    Here we report fluorescence quenching and electrophoretic mobility shift assays that probe siRNA b
256                         We demonstrate using electrophoretic mobility shift assays that Rv0678 binds
257                             When examined by electrophoretic mobility shift assay, the triterpenoid s
258                                           In electrophoretic mobility shift assays, the C allele of r
259                            However, based on electrophoretic mobility shift assays, the divergent CTR
260                                           In electrophoretic mobility shift assays, the purified rPG2
261                                        In an electrophoretic mobility shift assay, this protein produ
262                               In addition to electrophoretic mobility shift assays, this model was co
263                       In this study, we used electrophoretic mobility shift assay to analyze 46 aryls
264 gth and truncated forms of CpsA were used in electrophoretic mobility shift assays to characterize th
265 ariants of bacteriophage lambda Cro and used electrophoretic mobility shift assays to compare binding
266                  We used deep sequencing and electrophoretic mobility shift assays to derive in vitro
267 ylogenetic relations, in situ hybridization, electrophoretic mobility shift assays to determine bindi
268 mapping, data on DNase hypersensitivity, and electrophoretic mobility shift assays to study protein-D
269                                      We used electrophoretic mobility shift assay, transient transcri
270 ht mass spectrometry of a band excised after electrophoretic mobility shift assay using a ZTRE probe.
271 f detecting nuclear transcription factors by electrophoretic mobility shift assay using digoxigenin (
272                                              Electrophoretic mobility shift assays using mouse retina
273                                              Electrophoretic mobility shift assays using nuclear prot
274                                              Electrophoretic mobility shift assays using the ilvE pro
275                                              Electrophoretic mobility shift assays verified formation
276                                           An electrophoretic mobility shift assay was used to determi
277                       Use of the methods for electrophoretic mobility shift assays was demonstrated f
278 rcular dichroism, NMR, microcalorimetry, and electrophoretic mobility shift assay), we have character
279 me-linked immunosorbent assay (ELISA) and an electrophoretic mobility shift assay, we found that the
280      Using chromatin immunoprecipitation and electrophoretic mobility shift assay, we show that TH ha
281                                           By electrophoretic mobility shift assays, we confirmed bind
282 From the results of in vitro translation and electrophoretic mobility shift assays, we demonstrate th
283          Using fluorescence polarization and electrophoretic mobility shift assays, we demonstrate th
284 recipitation, site-directed mutagenesis, and electrophoretic mobility shift assays, we identified a G
285                                        Using electrophoretic mobility shift assays, we identified CRE
286                                           By electrophoretic mobility shift assays, we identified fou
287                      Using reporter gene and electrophoretic mobility shift assays, we identify an 11
288                                        Using electrophoretic mobility shift assays, we observed diffe
289                                           By electrophoretic mobility shift assays, we show weaker bi
290    Surface plasmon resonance diffraction and electrophoretic mobility shift assays were consistent wi
291                                              Electrophoretic mobility shift assays were used to asses
292                       In silico analysis and electrophoretic mobility shift assays were used to asses
293 nsfection, promoter/reporter constructs, and electrophoretic mobility shift assays were used to deter
294 on citZ transcription were also reflected in electrophoretic mobility shift assays where CcpE bound t
295 ding motifs were investigated by competitive electrophoretic mobility shift assay, which revealed tha
296 veral transcription factor-binding sites and electrophoretic mobility shift assays with MCF-7 nuclear
297                                              Electrophoretic mobility shift assays with PARP-1-specif
298                                              Electrophoretic mobility shift assays with purified His(
299 ly as determined by DNase I footprinting and electrophoretic mobility shift assays, with some DNA-bin
300              Using yeast 3 hybrid assays and electrophoretic mobility shift assays, Zar2 was shown to

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top